Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Date:8/8/2011

MALVERN, Pa., Aug. 8, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that Dr. James P. Tursi has been promoted to Chief Medical Officer. Dr. Tursi will report to Armando Anido, Chief Executive Officer and President of Auxilium, and sit on the Auxilium Executive Committee in this role.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

Dr. Tursi has been employed at Auxilium since March of 2009 and has been responsible for the oversight of clinical development, clinical operations, biometrics and medical writing.  He led a team of 30 individuals involved in clinical activities across several indications.  Dr. Tursi played critical roles in the preparation, submissions and approvals of the XIAFLEX® U.S. biologics license application and XIAPEX® European marketing authorization application for Dupuytren's contracture, as well as design of subsequent phase IV clinical trials.  He also has led the Peyronie's phase III program development and overseen enrollment of these pivotal clinical studies.  

Prior to Auxilium, Dr. Tursi entered the pharmaceutical industry in 2004 as a medical director for Procter and Gamble Pharmaceuticals. He worked on several products and therapeutic areas, which included female sexual dysfunction, overactive bladder, and osteoporosis. His responsibilities included Clinical Development and Medical Affairs. He moved to GlaxoSmithKline Biologicals in 2006 and directed all Medical Affairs responsibilities for cancer vaccines in North America.  

Dr. Tursi received his doctor of medicine degree from the Medical College of Pennsylvania. He subsequently completed his training in Gynecology and Obstetrics at the Johns Hopkins Hospital and entered clinical practice in Southern New Jersey caring for indigent patients. He pr
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
(Date:9/22/2014)... Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... fiscal 2014 ended July 31, 2014 on Monday, September 29 ... discuss the results at 11:00 AM ET. Participating in the ... Andrew A. Krakauer , President and CEO; Jorgen B. ... Sheldon , Senior Vice President, CFO and Treasurer; and ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- New research raises doubts ... cancer. Smokers with cancer who used e-cigarettes along ... those who didn,t use the devices, a Memorial Sloan ... likely -- or less likely -- to have quit ... The study, published online Sept. 22 in Cancer ...
(Date:9/22/2014)... Montreal, Quebec (PRWEB) September 22, 2014 ... understanding of chronic myelogenous leukemia, a form of blood ... CML is caused by a mutation affecting chromosomes 22 ... become a powerful symbol as the worldwide community unites ... it affects. , CML is at the forefront of ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 ... City, has just posted a new article to its ... feel more than just a tad dismayed. Titled “Coffee ... article, http://www.lifeant.com/coffee-drinkers-beware-paying-life-insurance/ states on average, coffee fans ... premiums than those who do not enjoy the tasty ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 As football season ... starting to put together their fantasy football leagues to prep ... also prepping as they work on new ways to bring ... Mica Lounge, located in the Sheraton Silver Spring Hotel, is ... own “Sheraton League” where locals and hotel guests can sign ...
(Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... - Dr. Beth Schrope , NewYork-Presbyterian/Columbia University ... or auto islet surgery, to prevent diabetes in ... is the first center in the New York ... Every year, roughly 87,000 people in the United ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Don't Help Cancer Patients Quit Smoking: Study 2Health News:Marking World CML Day on September 22nd 2Health News:Marking World CML Day on September 22nd 3Health News:Coffee Drinkers Are Charged More For Life Insurance, Reports LifeAnt.com 2Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 2Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 3Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 4Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 2Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 3
... A new study investigating the potential beneficial effects ... of anti-TNFa treatment in aging," appears in the ... ,This study shows hope for significantly ... been linked to blood vessel dysfunction and cell ...
... to your high blood pressure might just be your ... evidence suggests that inflammation, a part of the immune ... diabetes, may also help translate stress into high blood ... is an inflammatory condition,” says Dr. Haidong Zhu, molecular ...
... reduction pill, which works better and faster than existing drugs// ... and cancer. ,Existing anti-obesity pills generally cut weight ... ,But men and women taking Excalia, the new ... lost 12 percent of their body weight, according to the ...
... undergo a double hand transplant was ecstatic as she got ... "I'm doing very well, I'm very happy. I'm taking steps ... life. When I saw the hands after the operation, they ... her arms following an explosion in a laboratory in 1978, ...
... better safety for patients in ICU by adhering to ... threatening// catheter-related infections. ICUs can become thoroughly aseptic by ... syringes and catheters. A detailed report was made by ... of the report are published in New England Journal ...
... more people succumbed to Rift Valley Fever in Garissa district, ... has been made by the North Eastern Provincial// Medical Officer ... cautioned the public to seek medical attention as quickly as ... the disease is due to lack of awareness. But local ...
Cached Medicine News:Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 3Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2
... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
... VerifyNow Clopidogrel Assay measures changes in ... taking Clopidogrel (Plavix). It uses a ... which clopidogrel inhibits. The assay has ... however, the assay is available for ...
Medicine Products: